cobalt has been researched along with nicotianamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, A; Kimoto, K | 1 |
Arnoux, P; Borezée-Durant, E; Brutesco, C; Cava, F; Espaillat, A; Fojcik, C; Ghssein, G; Hajjar, C; Izaute, A; Lemaire, D; Lobinski, R; Ouerdane, L; Pignol, D; Richaud, P; Voulhoux, R; Wang, S | 1 |
2 other study(ies) available for cobalt and nicotianamine
Article | Year |
---|---|
Nicotianamine preferentially inhibits Angiotensin I-converting enzyme.
Topics: Alkaline Phosphatase; Angiotensin-Converting Enzyme Inhibitors; Animals; Azetidinecarboxylic Acid; Chelating Agents; Cobalt; Copper; Edetic Acid; Hypertension; Inhibitory Concentration 50; Leucyl Aminopeptidase; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Zinc | 2007 |
Biosynthesis of a broad-spectrum nicotianamine-like metallophore in Staphylococcus aureus.
Topics: Alkyl and Aryl Transferases; Amino Acid Isomerases; Azetidinecarboxylic Acid; Biosynthetic Pathways; Cobalt; Copper; Gene Expression Regulation, Bacterial; Histidine; Imidazoles; Metabolome; Nickel; Operon; Oxidoreductases; Staphylococcus aureus; Zinc | 2016 |